Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerAI sign LanguageOpen
VIPCreated with Sketch.

Lenvatinib plus anti-PD-1 antibodies as conversion therapy for patients with unresectable intermediate-advanced hepatocellular carcinoma: a single-arm, phase II trial.

Wenwen Zhang,Shuang Tong,Bingyang Hu,Tao Wan,Haowen Tang,Feilong Zhao,Tianyu Jiao,Junfeng Li,Ze Zhang,Jinping Cai,Huiyi Ye,Zhanbo Wang,Shiqing Chen, Yafei Wang,Xuerui Li,Fangzhou Wang,Junning Cao,Lantian Tian,Xiaochen Zhao,Mingyi Chen,Hongguang Wang,Shouwang Cai,Minggen Hu,Yuezong Bai, Shichun Lu

Journal for immunotherapy of cancer（2023）

Cited 0|Views11
No score
Abstract
Chinese Clinical Trial Registry, ChiCTR1900023914.
More
Translated text
Key words
Immunotherapy, Drug Therapy, Combination, Immune Checkpoint Inhibitors, Liver Neoplasms
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined